Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Charles
Robertson II has joined Cowen and Company’s Equity Research department
as a Director to cover oil & gas exploration & production (E&P) stocks.
Comstock Homes of Washington, LC, a wholly owned subsidiary of Comstock
Holding Companies, Inc. (NASDAQ:CHCI), announced that it has acquired 24
developed building lots, known as The Estates at Leeland, in
Fredericksburg, Virginia within Stafford County.
Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that they have
entered into a clinical trial collaboration with GlaxoSmithKline LLC to
evaluate a novel combination therapy targeting mutant epidermal growth
factor receptor (EGFR) non-small cell lung cancer (NSCLC). The Phase 1/2
trial of rociletinib given in combination with trametinib is planned to
start in 1H 2015.
FleetCor Technologies, Inc. (NYSE:FLT), a leading global provider of
fuel cards and workforce payment products to businesses, today announced
that it has completed the previously announced acquisition of Comdata
Inc. (“Comdata”) from Ceridian LLC, a portfolio company of funds
affiliated with Thomas H.
Old Dominion Freight Line, Inc. (NASDAQ: ODFL) today announced that its
Board of Directors has approved a stock repurchase program authorizing
Old Dominion to repurchase up to $200 million of its outstanding common
stock over the next 24 months.
Third-Quarter 2014 Financial Highlights - Third-quarter revenues of $27.6 million, up 14.3% year-over-year; year-to-date revenue up by 57.9% - Quarterly Gross Margin at 39.4%, as compared to 39.5% year over year, and 37.8% quarter over quarter
- Quarterly Non-GAAP net income of $3.5 million, up 75.4% year over year - Non-GAAP diluted EPS at $0.12 per ADS reported for the quarter, up 100% year over year -Year-to-date Non-GAAP net income of $3.0 million, non-GAAP diluted EPS at $0.11 per ADS BEIJING , Nov.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against 21Vianet Group, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of November 11, 2014 -- VNET investment picks
OvaScience SM (NASDAQ:OVAS), a global life sciences company
focused on the discovery, development and commercialization of new
fertility treatments, today reported third quarter 2014 financial
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.